Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area
Clinical trial NCT03101111 · COMPLETED
Trial details
- NCT number
- NCT03101111
- Sponsor
- Themis Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-09
- Primary completion
- 2019-04-02
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.